EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Recent advances and applications of nitroreductase activable agents for tumor theranostic

Baoxin Shang, Zongjiang Yu, Zhengdan Wang

Frontiers in Pharmacology · 19.07.2024 · 15

DOI: 10.3389/fphar.2024.1451517 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 19.07.2024. Verfasst von Baoxin Shang und 2 weiteren Autor:innen. Beteiligte Einrichtung: The Afffliated Hospital of Qingdao University, Qingdao University, Qingdao, China. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nitroreductase activable agents offer a personalized and targeted approach to cancer theranostics by selectively activating prodrugs within the tumor microenvironment. These agents enable non-invasive tumor imaging, image-guided drug delivery, and real-time treatment monitoring. By leveraging the enzymatic action of tumor-specific nitroreductase enzymes, cytotoxic drugs are delivered directly to cancer cells while minimizing systemic toxicity. This review highlights the key features, mechanisms of action, diagnostic applications, therapeutic potentials, and future directions of nitroreductase activable agents for tumor theranostics. Integration with imaging modalities, advanced drug delivery systems, immunotherapy combinations, and theranostic biomarkers shows promise for optimizing treatment outcomes and improving patient survival in oncology. Continued research and innovation in this field are crucial for advancing novel theranostic strategies and enhancing patient care. Nitroreductase activable agents represent a promising avenue for personalized cancer therapy and have the potential to transform cancer diagnosis and treatment approaches.

Schlagwörter

Stichwörter der Autor:innen

enzyme-responsive prodrugsnitroreductase activable agentsreal-time imagingtargeted drug deliverytumor theranostics

Autor:innen und Institutionen

  • The Afffliated Hospital of Qingdao University, Qingdao University, Qingdao, China.
  • CAS Key Laboratory of Biobased Materials, Qingdao Institute of Bioenergy and Bioprocess Technology, Chinese Academy of Sciences, Qingdao, China.
  • Shandong Energy Institute, Qingdao, China.
  • Qingdao New Energy Shandong Laboratory, Qingdao, China.

Zitieren

APA

Shang, B., Yu, Z., & Wang, Z. (2024). Recent advances and applications of nitroreductase activable agents for tumor theranostic. Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1451517

Vancouver

Shang B, Yu Z, Wang Z. Recent advances and applications of nitroreductase activable agents for tumor theranostic. Frontiers in Pharmacology. 2024;15. doi:10.3389/fphar.2024.1451517

BibTeX
@article{Shang2024,
  author = {Shang, Baoxin and Yu, Zongjiang and Wang, Zhengdan},
  title = {Recent advances and applications of nitroreductase activable agents for tumor theranostic},
  journal = {Frontiers in Pharmacology},
  year = {2024},
  volume = {15},
  doi = {10.3389/fphar.2024.1451517}
}
Kostenlos starten →